165 related articles for article (PubMed ID: 3037770)
21. Kit expression in small cell carcinomas of the lung: effects of chemotherapy.
Rossi G; Cavazza A; Marchioni A; Migaldi M; Bavieri M; Facciolongo N; Petruzzelli S; Longo L; Tamberi S; Crinò L
Mod Pathol; 2003 Oct; 16(10):1041-7. PubMed ID: 14559988
[TBL] [Abstract][Full Text] [Related]
22. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
[TBL] [Abstract][Full Text] [Related]
23. Immunocytochemical demonstration of intermediate filament cytoskeleton proteins in human endocrine tissues and (neuro-) endocrine tumours.
Hoefler H; Denk H; Lackinger E; Helleis G; Polak JM; Heitz PU
Virchows Arch A Pathol Anat Histopathol; 1986; 409(5):609-26. PubMed ID: 3092460
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibody 123C3 in lung tumour classification. Immunohistology of 358 resected lung tumours.
Mooi WJ; Wagenaar SS; Schol D; Hilgers J
Mol Cell Probes; 1988 Mar; 2(1):31-7. PubMed ID: 2837665
[TBL] [Abstract][Full Text] [Related]
25. CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas.
Pelosi G; Masullo M; Leon ME; Veronesi G; Spaggiari L; Pasini F; Sonzogni A; Iannucci A; Bresaola E; Viale G
Virchows Arch; 2004 Nov; 445(5):449-55. PubMed ID: 15375659
[TBL] [Abstract][Full Text] [Related]
26. Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors.
Yamaguchi K; Abe K; Kameya T; Adachi I; Taguchi S; Otsubo K; Yanaihara N
Cancer Res; 1983 Aug; 43(8):3932-9. PubMed ID: 6861155
[TBL] [Abstract][Full Text] [Related]
27. Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors.
Lantuejoul S; Moro D; Michalides RJ; Brambilla C; Brambilla E
Am J Surg Pathol; 1998 Oct; 22(10):1267-76. PubMed ID: 9777989
[TBL] [Abstract][Full Text] [Related]
28. Peptide hormone production in small cell lung carcinomas with particular reference to gastrin-releasing peptide.
Yamaguchi K; Abe K; Adachi I; Otsubo K; Nagasaki K; Suzuki M; Maruno K; Asanuma F; Tsuchihashi T; Miyake Y
Jpn J Clin Oncol; 1986 Sep; 16(3):235-41. PubMed ID: 3022032
[TBL] [Abstract][Full Text] [Related]
29. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
[TBL] [Abstract][Full Text] [Related]
30. Lung tumours immunoreactive for parathyroid hormone related peptide: analysis of serum calcium levels and tumour type.
Davidson LA; Black M; Carey FA; Logue F; McNicol AM
J Pathol; 1996 Apr; 178(4):398-401. PubMed ID: 8691317
[TBL] [Abstract][Full Text] [Related]
31. Immunostaining for vasostatin I distinguishes between ileal and lung carcinoids.
Cunningham RT; Pogue KM; Curry WJ; Johnston CF; Sloan JM; Buchanan KD
J Pathol; 1999 Feb; 187(3):321-5. PubMed ID: 10398086
[TBL] [Abstract][Full Text] [Related]
32. Production of immunoreactive atrial natriuretic polypeptide in neuroendocrine tumors.
Yoshinaga K; Yamaguchi K; Abe K; Inoue T; Mishima Y
Cancer; 1994 Feb; 73(4):1292-6. PubMed ID: 8313333
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of small cell lung carcinoma; with special reference to the neuroendocrine markers aromatic L-amino acid decarboxylase and gastrin-releasing peptide.
Nakajima T; Shimosato Y; Morinaga S; Terasaki T; Tsumuraya M; Yamaguchi K; Ichinose H; Nagatsu T; Kato K; Nakazato Y
Jpn J Clin Oncol; 1986 Sep; 16(3):223-33. PubMed ID: 2430122
[TBL] [Abstract][Full Text] [Related]
34. Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumours.
Vieau D; Linard CG; Mbikay M; Lenne F; Chretien M; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1992 Jun; 36(6):597-603. PubMed ID: 1424185
[TBL] [Abstract][Full Text] [Related]
35. Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours.
Kasprzak A; Olejniczak K; Przybyszewska W; Zabel M
Folia Morphol (Warsz); 2007 Aug; 66(3):159-66. PubMed ID: 17985312
[TBL] [Abstract][Full Text] [Related]
36. Detection of human probombesin mRNA in neuroendocrine (small cell) carcinoma of the lung. In situ hybridization with cRNA probe.
Hamid QA; Bishop AE; Springall DR; Adams C; Giaid A; Denny P; Ghatei M; Legon S; Cuttitta F; Rode J
Cancer; 1989 Jan; 63(2):266-71. PubMed ID: 2535954
[TBL] [Abstract][Full Text] [Related]
37. Differential diagnostic patterns of lung neuroendocrine tumours. A clinico-pathological and immunohistochemical study of 122 cases.
Bonato M; Cerati M; Pagani A; Papotti M; Bosi F; Bussolati G; Capella C
Virchows Arch A Pathol Anat Histopathol; 1992; 420(3):201-11. PubMed ID: 1372778
[TBL] [Abstract][Full Text] [Related]
38. Expression and ligand binding of bombesin receptors in pulmonary and intestinal carcinoids.
Kuiper P; Verspaget HW; Biemond I; de Jonge-Muller ES; van Eeden S; van Velthuysen ML; Taal BG; Lamers CB
J Endocrinol Invest; 2011 Oct; 34(9):665-70. PubMed ID: 21060250
[TBL] [Abstract][Full Text] [Related]
39. Nicotine effects on proliferation and the bombesin-like peptide autocrine system in human small cell lung carcinoma SHP77 cells in culture.
Novak J; Escobedo-Morse A; Kelley K; Boose D; Kautzman-Eades D; Meyer M; Kane MA
Lung Cancer; 2000 Jul; 29(1):1-10. PubMed ID: 10880842
[TBL] [Abstract][Full Text] [Related]
40. Production of gastrin-releasing peptide-(18-27) and a stable fragment of its precursor in small cell lung carcinoma cells.
Vangsted AJ; Schwartz TW
J Clin Endocrinol Metab; 1990 Jun; 70(6):1586-93. PubMed ID: 1693372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
